Qiming Venture Partners ("Qiming") today launched its first “Catalyst: Qiming Healthcare Summer Program 2023” for universities in Hong Kong, fostering talent development and cross-border integration for the life science, medical and healthcare sectors between Hong Kong and Mainland China. This unique, highly selective program offers a platform for young Hong Kong scientists to gain exclusive access to China’s leading companies in biotech and healthcare.

Spanning 7 days in 3 cities (Beijing, Shanghai and Suzhou) visiting a series of leading companies, entrepreneurs and top-tier startups, the Qiming Healthcare Program offers participants a privileged insight into China’s healthcare ecosystem, to gain first-hand understanding of how scientific discoveries are commercialised, facilitating participants to build career-defining relationships with entrepreneurs and leaders in the sector. It can also be a channel for participants to identify great opportunities for future career development.

Qiming Healthcare Program invites postgraduates (PhD, MPhil or equivalent qualification) in life science, biotechnology, medicine, engineering, bioinformatics and related disciplines at local universities in Hong Kong to participate. The program consists of company and facility visits, entrepreneur sharing, frontier technology debate as well as an award competition for participants.

A surge of innovation, supportive policies, and public-private-academic partnerships are propelling China’s healthcare sector to the global stage. Hong Kong, as part of the Greater Bay Area (GBA), is committed to establishing itself as a healthcare and biotech innovation hub.

“Talent development is a key element in supporting and sustaining this effort,” said Nisa Leung, Managing Partner of Qiming Venture Partners. “It is critical for our young scientists in Hong Kong to gain deeper understanding of the latest developments in China.”

As one of China’s most active venture capital firms, Qiming Venture Partners has fostered the growth of nearly 200 innovative medical and healthcare companies, covering a full range of the healthcare ecosystem such as biotechnology, medical devices, diagnostics and services. Over 100 of its portfolio companies have become leading players in their respective fields.

“We strongly encourage the best and brightest students to grasp this unique opportunity, joining us on this journey to reshape the future of healthcare,” added Leung.

Program details: